Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival.

MLA

Segatto, Marco, et al. “Epigenetic Targeting of Bromodomain Protein BRD4 Counteracts Cancer Cachexia and Prolongs Survival.” Nature Communications, vol. 8, no. 1, Nov. 2017, p. 1707. EBSCOhost, https://doi.org/10.1038/s41467-017-01645-7.

APA

Segatto, M., Fittipaldi, R., Pin, F., Sartori, R., Dae Ko, K., Zare, H., Fenizia, C., Zanchettin, G., Pierobon, E. S., Hatakeyama, S., Sperti, C., Merigliano, S., Sandri, M., Filippakopoulos, P., Costelli, P., Sartorelli, V., & Caretti, G. (2017). Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival. Nature Communications, 8(1), 1707. https://doi.org/10.1038/s41467-017-01645-7

Chicago

Segatto, Marco, Raffaella Fittipaldi, Fabrizio Pin, Roberta Sartori, Kyung Dae Ko, Hossein Zare, Claudio Fenizia, et al. 2017. “Epigenetic Targeting of Bromodomain Protein BRD4 Counteracts Cancer Cachexia and Prolongs Survival.” Nature Communications 8 (1): 1707. doi:10.1038/s41467-017-01645-7.